Dasatinib D8 is a octa-deuterated form (in the piperazine ring) of Dasatinib (BMS-354825; Sprycel), which is an approved anticancer drug acting as a dual Bcr-Abl and Src family tyrosine kinase inhibitor.

纯度：≥98%

CAS：1132093-70-9